scholarly journals The Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Chilean National Health Fund (Fonasa)

2016 ◽  
Vol 19 (7) ◽  
pp. A431
Author(s):  
C Noda ◽  
JA de Anda ◽  
P Anaya ◽  
P Serafini ◽  
M Machado
Keyword(s):  
Multiple Sclerosis ◽  
Cost Effectiveness ◽  
Glatiramer Acetate ◽  
National Health ◽  
Dimethyl Fumarate ◽  
Health Fund ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
The Cost ◽  
Relapsing Remitting Multiple Sclerosis

Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis

2009 ◽  
Vol 7 (2) ◽  
pp. 91-108 ◽  
Author(s):  
Stephanie R. Earnshaw ◽  
Jonathan Graham ◽  
MerriKay Oleen-Burkey ◽  
Jane Castelli-Haley ◽  
Kenneth Johnson
Keyword(s):  
Multiple Sclerosis ◽  
Cost Effectiveness ◽  
Glatiramer Acetate ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis
Sign in / Sign up

Export Citation Format

Share Document